NHS Approves First Drug to Delay Type 1 Diabetes

The NHS in England and Wales approved teplizumab, the world's first drug to delay the onset of type 1 diabetes for up to three years.

The immunotherapy treatment targets the autoimmune process that destroys insulin-producing cells.

The landmark decision offers hope to thousands at risk of developing the condition, marking a significant shift from managing diabetes to actively preventing it.

The drug works by interrupting the body's attack on its own pancreatic beta cells.